Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Generation Bio Co.
(NQ:
GBIO
)
2.210
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Nov 1, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Generation Bio Co.
< Previous
1
2
Next >
Generation Bio Announces the Presentation of Preclinical Data on ctLNP and iqDNA at the ESGCT 31st Annual Congress
October 22, 2024
From
Generation Bio Co.
Via
GlobeNewswire
Generation Bio to Present at the 2024 Cantor Global Healthcare Conference
September 12, 2024
From
Generation Bio Co.
Via
GlobeNewswire
Generation Bio Reports Second Quarter 2024 Financial Results
August 07, 2024
Cash balance of $217 million still expected to fund operations into 2H 2027
From
Generation Bio Co.
Via
GlobeNewswire
Generation Bio to Present at the Canaccord Genuity 44th Annual Growth Conference
August 06, 2024
From
Generation Bio Co.
Via
GlobeNewswire
Generation Bio to Present at the 2024 TD Cowen Genetic Medicines & RNA Summit
June 14, 2024
From
Generation Bio Co.
Via
GlobeNewswire
Generation Bio Announces Recent Business Highlights and First Quarter 2024 Financial Results
May 13, 2024
From
Generation Bio Co.
Via
GlobeNewswire
Generation Bio Announces the Presentation of Preclinical Data on iqDNA and ctLNP Platforms at the ASGCT 27th Annual Meeting
May 09, 2024
From
Generation Bio Co.
Via
GlobeNewswire
Generation Bio Announces the Acceptance of Five Abstracts and an Invited Oral Presentation at the American Society of Gene and Cell Therapy (ASGCT) 27th Annual Meeting
April 22, 2024
From
Generation Bio Co.
Via
GlobeNewswire
Generation Bio to Present at the 23rd Annual Needham Virtual Healthcare Conference
April 02, 2024
From
Generation Bio Co.
Via
GlobeNewswire
Generation Bio Reports Business Highlights and Fourth Quarter and Full Year 2023 Financial Results
March 06, 2024
From
Generation Bio Co.
Via
GlobeNewswire
Generation Bio to Present at the 2024 TD Cowen Health Care Conference
February 27, 2024
From
Generation Bio Co.
Via
GlobeNewswire
Generation Bio to Present at the 42nd Annual J.P. Morgan Healthcare Conference
January 03, 2024
From
Generation Bio Co.
Via
GlobeNewswire
Generation Bio Announces Strategic Reorganization to Extend Cash Runway for Development of ctLNP and iqDNA Platforms
November 29, 2023
From
Generation Bio Co.
Via
GlobeNewswire
Generation Bio Reports Business Highlights and Third Quarter 2023 Financial Results
November 09, 2023
From
Generation Bio Co.
Via
GlobeNewswire
Generation Bio Announces Demonstration of Highly Selective T Cell Transduction In Vivo with Cell-Targeted LNP Platform
October 26, 2023
From
Generation Bio Co.
Via
GlobeNewswire
Generation Bio Announces Breakthrough in its Non-Viral Genetic Medicine Platform with Novel “Immune-Quiet” DNA
October 18, 2023
From
Generation Bio Co.
Via
GlobeNewswire
Generation Bio to Present at the Jefferies Cell & Genetic Medicine Summit
September 19, 2023
From
Generation Bio Co.
Via
GlobeNewswire
Generation Bio to Present at the Canaccord Genuity 43rd Annual Growth Conference
August 03, 2023
From
Generation Bio Co.
Via
GlobeNewswire
Generation Bio Reports Second Quarter 2023 Financial Results
August 02, 2023
Second quarter 2023 cash balance of $314.1 million expected to fund operations into 2025
From
Generation Bio Co.
Via
GlobeNewswire
Generation Bio to Present at the 2023 Jefferies Healthcare Conference
May 31, 2023
From
Generation Bio Co.
Via
GlobeNewswire
Generation Bio Reports Business Highlights and First Quarter 2023 Financial Results
May 10, 2023
From
Generation Bio Co.
Via
GlobeNewswire
Generation Bio to Present at the JMP Securities Life Sciences Conference
May 09, 2023
From
Generation Bio Co.
Via
GlobeNewswire
Generation Bio to Present at the 22nd Annual Needham Virtual Healthcare Conference
April 11, 2023
From
Generation Bio Co.
Via
GlobeNewswire
Generation Bio Appoints Yalonda Howze, J.D. as Chief Legal Officer
April 05, 2023
From
Generation Bio Co.
Via
GlobeNewswire
Generation Bio Co. (NASDAQ: GBIO) Leading the Way in Thursday Trading Based on Percentage Gain
March 23, 2023
Via
Investor Brand Network
Moderna and Generation Bio Announce Strategic Collaboration to Develop Non-Viral Genetic Medicines
March 23, 2023
From
Generation Bio Co.; Moderna
Via
GlobeNewswire
Generation Bio to Participate in the BMO Biopharma Spotlight Series: Novel Technologies for the Delivery of Genetic Medicines
March 21, 2023
From
Generation Bio Co.
Via
GlobeNewswire
Generation Bio to Present at the 43rd Annual Cowen Healthcare Conference
February 27, 2023
From
Generation Bio Co.
Via
GlobeNewswire
Generation Bio Outlines 2023 Strategic Priorities and Reports Fourth Quarter and Full Year 2022 Financial Results
February 23, 2023
From
Generation Bio Co.
Via
GlobeNewswire
Generation Bio to Present at the 41st Annual J.P. Morgan Healthcare Conference
January 03, 2023
From
Generation Bio Co.
Via
GlobeNewswire
< Previous
1
2
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.